Genic Co. Ltd. (123330) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genic Co. Ltd. (123330:KRX), powered by AI.

Current Price
₩31,000
P/E Ratio
29.9
Market Cap
247.0B
Sector
Consumer Defensive
What is the Genic Co. Ltd. stock price forecast?

Genic Co. Ltd. is currently trading at ₩31,000. View real-time AI analysis on Alpha Lenz.

What is Genic Co. Ltd. insider trading activity?

View the latest insider trading data for Genic Co. Ltd. on Alpha Lenz.

What is Genic Co. Ltd.'s P/E ratio?

Genic Co. Ltd.'s P/E ratio is 29.9.

Genic Co. Ltd.

KRX · 123330
₩31,000
Ask about Genic Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Genic Co. Ltd. trades at a P/E of 29.9 (premium valuation) with strong ROE of 44.9%.

Ask for details

Company Overview

Genic Co. Ltd. is a company specializing in the design, development, and manufacturing of an extensive range of cosmetic products. It focuses primarily on skincare items, which include creams, lotions, serums, and other topical solutions aimed at enhancing and nourishing skin health. The company places a strong emphasis on research and innovation, utilizing cutting-edge technology and scientific advancements to produce high-quality products that cater to various skin types and conditions. Operating in the highly competitive personal care sector, Genic Co. Ltd. plays a significant role in impacting beauty trends and consumer preferences both domestically and internationally. The company is committed to sustainability and eco-friendliness, often incorporating natural ingredients and environmentally conscious practices in its production processes. As a key player in the cosmetic industry, Genic Co. Ltd. contributes to shaping the market landscape through its innovative offerings and dedication to customer satisfaction, establishing itself as a trusted name in skincare solutions.

CEO허남
SectorConsumer Defensive
IndustryHousehold & Personal Products
Employees324

Company Statistics

FY 2024

Profile

₩247,029,080,000Market Cap
₩49,908,316,630Revenue
7.97MShares Out
324Employees

Margins

23.27%Gross
15.49%EBITDA
12.07%Operating
11.38%Pre-Tax
15.15%Net

Valuation

29.94P/E
10.22P/B
4.54EV/Sales
29.89EV/EBITDA
-164.23P/FCF

Growth (CAGR)

9.12%Rev 3Yr
2.95%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

24.57%ROA
44.90%ROE
19.80%ROIC

Financial Health

₩1,289,836,130Cash & Cash Equivalents
₩14,713,032,980Net Debt
72.23%Debt/Equity
N/AInterest Cov
Alpha Chat Insight

Genic Co. Ltd. trades at a P/E of 29.9 (premium valuation) with strong ROE of 44.9%.

Ask for details

Frequently Asked Questions

Genic Co. Ltd. (ticker: 123330) is a company listed on KRX in the Consumer Defensive sector (Household & Personal Products). It has approximately 324 employees. Market cap is $247.0B.

The current price is ₩31,000 with a P/E ratio of 29.94x and P/B of 10.22x.

ROE is 44.90% and operating margin is 12.07%. Annual revenue is $49.9B.

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Genic Co. Ltd. (Consumer Defensive) Stock Forecast & Analysis ₩31,000 | Alpha Lenz